Tandem Diabetes Care News

Tandem Diabetes Care Global Market Insights, Inc / May 2, 2022

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Rating) have been given an average rating of “Hold” by the thirteen ratings firms that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and s…

Tandem Diabetes Care Global Market Insights, Inc / May 2, 2022

Some of the major companies operating in the insulin delivery devices industry include Sanofi, Becton, Eli Lilly, Novo Nordisk, Roche, Insulet Corporation,...

Tandem Diabetes Care Ripon College Days / Apr 30, 2022

New Jersey, United States - The latest research report provides a complete assessment of the Smart D

Tandem Diabetes Care Medtech Insight / Apr 29, 2022

Rowelto Associates has the latest research report titled Global Diabetes Devices Market 2022 by Manu

Tandem Diabetes Care Medtech Insight / Apr 29, 2022

Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, today announced the final closings for the Breakthrough Life Science Property Fund. The venture raised $3 billion in direct capital and co-investments, to scale a global portfolio of best-in-class ecosystems for dynamic…

Tandem Diabetes Care Medtech Insight / Apr 29, 2022

Wall Street brokerages predict that Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Rating) will post $168.50 million in sales for the current fiscal quarter, according to Zacks. Five analysts have made estimates for Tandem Diabetes Care’s earnings. The lowest sales estimate is $166.00 million and the…

Tandem Diabetes Care Medtech Insight / Apr 29, 2022

<p>Chad Patterson, Dexcom’s executive vice president of global marketing and product management, talked to <i>Medtech Insight</i> about the premium continuous glucose monitor manufacturer’s plans for facing stiff competition over the coming years.</p>

Tandem Diabetes Care Ripon College Days / Apr 27, 2022

Tandem Diabetes Care (NASDAQ:TNDM – Get Rating) will be releasing its earnings data after the market closes on Wednesday, May 4th. Analysts expect Tandem Diabetes Care to post earnings of $0.02 per share for the quarter. Tandem Diabetes Care has set its FY 2022 guidance at EPS.Parties interested in…

Tandem Diabetes Care Ripon College Days / Apr 27, 2022

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced real-world data confirming that use of the t:slim X2™ insulin pump with Control-IQ® advanced hybrid

Tandem Diabetes Care Ripon College Days / Apr 27, 2022

New Jersey, United States - The study is a professional and comprehensive assessment of the Con